Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1991-12-17
|
pubmed:abstractText |
The use of radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphoma offers the hope of delivering radiation to tumor with relative specificity, thereby providing significant antitumor effects with limited toxicity. In this article the results of recently initiated trials are summarized, and the major unresolved issues concerning this approach are reviewed.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0889-8588
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1013-25
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1938754-Animals,
pubmed-meshheading:1938754-Antibodies, Monoclonal,
pubmed-meshheading:1938754-Humans,
pubmed-meshheading:1938754-Iodine Radioisotopes,
pubmed-meshheading:1938754-Lymphoma, Non-Hodgkin,
pubmed-meshheading:1938754-Radioisotopes,
pubmed-meshheading:1938754-Whole-Body Irradiation
|
pubmed:year |
1991
|
pubmed:articleTitle |
Radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
|
pubmed:affiliation |
University of Washington School of Medicine, Seattle.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review
|